Sign in

CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522214851
Phone
617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
  1. 424B5 Offering Prospectus
  2. 424B5 Offering Prospectus
  3. 424B5 Offering Prospectus
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. S-3 Offering Registration Statement
  7. 424B5 Offering Prospectus
  8. 424B5 Offering Prospectus
  9. 424B5 Offering Prospectus
  10. 424B5 Offering Prospectus
  11. 424B5 Offering Prospectus
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. UPLOAD Other SEC-generated Letter
  14. S-3 Offering Registration Statement
  15. 424B4 Offering Prospectus
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1/A Offering Registration Statement
  19. S-1/A Offering Registration Statement
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 1 of 2 · 30 filings